METTL3 and diabetic kidney disease: Notably, only YTHDC2, WTAP, and METTL3 expression was increased in DKD patients with m6A changed regulators in glomerular samples, whereas the most were downregulated compared to controls, with FMR1 expression level drop having the biggest and most statistically significant fold change (Figure 1D).